Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 26
- Registration Number
- NCT00835354
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 36
- Registration Number
- NCT00834795
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Ribavirin 200 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 28
- Registration Number
- NCT00835146
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Metformin ER 750 mg Tablets, Fasting
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00834743
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
Glimepiride 4 mg Tablets Under Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00834340
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
Cefdinir for Oral Suspension 250 mg/5mL, Fasting
- Conditions
- Healthy
- Interventions
- Drug: OMNICEF® for oral suspension 250 mg/5mL
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00834574
- Locations
- 🇺🇸
Bioassay Laboratory, Inc., Houston, Texas, United States
🇺🇸Novum Pharmaceutical Research Services, Houston, Texas, United States
Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 58
- Registration Number
- NCT00834379
- Locations
- 🇨🇦
Pharma Medica Research Inc., Toronto, Ontario, Canada
Venlafaxine 25 mg Tablets Under Non-Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 18
- Registration Number
- NCT00834249
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Famciclovir 500 mg Tablets Under Non-Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 36
- Registration Number
- NCT00834444
- Locations
- 🇨🇦
Ba Research Co., Toronto, Ontario, Canada
🇺🇸Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Ribavirin 200 mg Tablets Under Non-Fasting Conditions
- Conditions
- Healthy
- Interventions
- Drug: COPEGUS™ 200 mg Tablets
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 27
- Registration Number
- NCT00835536
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States